$4.18 (-1.76%)

Volume: 205.096k

Closed: Nov 25, 2022

Hollow Logo Score: -4.046

Atara Biotherapeutics Stock Forecast

$4.18 (-1.76%)

Volume: 205.096k

Closed: Nov 25, 2022

Score Hollow Logo -4.046

Atara Biotherapeutics Stock Statistics NASDAQ:ATRA

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-11-17 - 2022-11-25 SELL -3.02
2022-11-10 - 2022-11-17 BUY -10.58
2022-11-09 - 2022-11-10 SELL 24.07
2022-11-04 - 2022-11-09 BUY -18.21
2022-11-03 - 2022-11-04 HOLD 2.15

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT